BioSpace News Archive

Titanium® Technology to Perform Influence Mapping in 15 European Countries

The Janssen Pharmaceutical Companiesof Johnson & Johnson today announced new real-world data that showed frail patients with non-valvular atrial fibrillation (NVAF) experienced significantly fewer strokes and systemic emboli when treated with XARELTO® (rivaroxaban) over a two-year period compared to those taking warfarin.

91 accepted abstracts at ASCO, including LYNPARZA® (olaparib) in prostate cancer and moxetumomab pasudotox in hairy cell leukemia

The addition of Cxbladder Monitor for bladder cancer surveillance has been shown to enable physicians to reduce the overall number of diagnostic tests being ordered, potentially reducing the total cost of monitoring and reducing complications related to unnecessary tests.

Treatment of agitation in the elderly in hospital and nursing home settings represents a rapid potential path to market for BNC210 No currently approved treatments and significant unmet medical need

Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR), a clinical-stage biopharmaceutical company focused on bringing to market novel product candidates for the treatment of rare diseases, announced today the pricing of its previously announced underwritten public offering.

Medtronic plc announced first-ever-data from the SPYRAL HTN-ON MED Study.

Clinical trial extends previous studies of SPL-108 in ovarian cancer

Cindy is a recognized leader in diagnostics, life sciences, and therapeutics. Prior to her most recent position as CEO of Human Longevity Inc.

The most precise and conformal Cancer Therapy, using hypo-fractionation, supported by a range of the most advanced cyclotrons for research and radioisotope production for medical diagnosis and therapy in the world